Quantitative and dynamic ctDNA as a biomarker of response and survival in lung squamous cancer patients receiving immunochemotherapy or chemotherapy alone

Multi-omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma

Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study)

An Expanding Universe of Mutational Signatures and Its Rapid Evolution in Single-Stranded RNA Viruse

Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted study